Ad Astra Diagnostics awarded $5 million federal contract for next gen CBC and sepsis diagnostic system

Oct 24, 2024•about 1 year ago

Contract Type

contract

North CarolinaBiotechnologyHealth Care

Description

Ad Astra Diagnostics has been awarded a $5 million federal contract with potential to award up to $12.6 million for the development of an improved diagnostic system designed to deliver faster complete blood count (CBC) test results and the earlier detection of severe infection, including sepsis. The QScout CBC system aims to be the most comprehensive patient-side CBC for earlier identification and triage of severe infection.

Company Information

Company

Ad Astra Diagnostics

Location

North Carolina, United States

About

Ad Astra Diagnostics is a developer of rapid diagnostic and data systems, aiming to improve patient-side CBC and the early detection of severe infections, including sepsis.

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months